CIK 0001321732
- Large accelerated filer
Penumbra Inc
Sign in to watch- Ticker
- PEN
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-995-2486
- Business address
- ONE PENUMBRA PLACE, ALAMEDA, CA, 94502
- 4 Open-market sale CEO and President sold 8,000 shares at an average $187.67 ($1,501,356)
- 4 Open-market sale Chief Innovator sold 10,000 shares at $185.07 ($1,850,700)
- 4 Open-market sale Chief Innovator sold 9,100 shares at an average $185.53 ($1,688,286)
- 4 Open-market sale Chief Innovator sold 900 shares at $185.11 ($166,599)
- 4 Open-market sale President sold 2,500 shares at an average $169.28 ($423,204)
- 4 Open-market sale Chief Executive Officer sold 8,000 shares at an average $157.81 ($1,262,493)
- 4 Open-market sale Director sold 44 shares at $162.56 ($7,153)
- 4 Open-market sale President sold 2,500 shares at an average $154.36 ($385,901)
- 4 Open-market sale Chief Executive Officer sold 8,000 shares at an average $172.01 ($1,376,096)
- 4 Open-market sale Director sold 304 shares at an average $186.30 ($56,635)
- 4 Open-market sale President sold 2,500 shares at an average $190.70 ($476,761)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale EVP and Chief Business Officer sold 5,000 shares at $185.25 ($926,250)
- 4 Open-market sale Chief Innovator sold 10,000 shares at $185.30 ($1,853,000)
- 4 Grant or award Director acquired 756 shares (grant or award)
- 4 Grant or award Director acquired 756 shares (grant or award)
- 4 Grant or award Director acquired 756 shares (grant or award)
- 4 Grant or award Director acquired 756 shares (grant or award)
Page 17 of 30 · 595 filings